Oral Answers to Questions Debate
Full Debate: Read Full DebateBaroness Ritchie of Downpatrick
Main Page: Baroness Ritchie of Downpatrick (Labour - Life peer)Department Debates - View all Baroness Ritchie of Downpatrick's debates with the Department for Exiting the European Union
(8 years ago)
Commons ChamberI assure my right hon. Friend that we will be looking very carefully at that. As I said earlier, no decisions have yet been made about the future location of the European Medicines Agency. Until we have left the EU, the UK remains a member with all the rights and obligations that membership entails. The Medicines and Healthcare products Regulatory Agency continues to play a full role in all procedures of the EU medical device regulatory framework.
What priority has the ministerial team given to achieving continued tariff-free access and continued membership of the single market?
Those are two different things. As I said earlier, we give very high priority to both tariff-free access and access without tariff barriers, at least no more than there are already—there are plenty. That may or may not include membership of the single market, but it is achievable by a number of different methods.